| AMAG Pharmaceuticals Inc. Q1 2010 Earnings Call Transcript AMAG Pharmaceuticals Inc. (AMAG)Q1 2010 Earnings CallApril 27, 2010 04:30 pm ETComplete Story » seekingalpha.com |
PPD completes spinoff of compound partnering unit (AP) Pharmaceutical Product Development Inc. said Tuesday it completed the spinoff of its compound partnering business into a separate publicly traded company called Furiex Pharmaceuticals Inc. us.rd.yahoo.com |
Maine Seeks Health-Care Waiver Maine's insurance regulator asked the Obama administration to temporarily exempt the state's health plans from a key provision of the federal health overhaul that would affect their profits. online.wsj.com |
Walgreen, Omnicare to Swap Assets Walgreen said same-store sales rose for the third straight month in August and disclosed it will swap most of its long-term-care pharmacy business for substantially all of Omnicare's home-infusion operations. online.wsj.com |
Positive Data on Vivus’ Weight-Loss Drug Qnexa Zacks.com submits: Vivus Inc. (VVUS) recently announced positive data from a two-year trial of its weight loss, once-daily pill Qnexa. The data, reported from the extended 52-week SEQUEL study, covered 675 overweight or obese patients. The SEQUEL trial followed the 56-week CONQUER trial.The patients who took the highest dose of Qnexa during the total 108 weeks of the study experienced and maintained an average weight loss of 11.4% or 26 pounds. The candidate was well tolerated in the SEQUEL study, with the most common adverse events being constipation, tingling, dry mouth, altered taste and insomnia.Complete Story » seekingalpha.com |